Adam Friedman, CEO of the Scorpion Therapeutics spinout, said the deal helps both companies accelerate research "faster than ...

June 24 (Reuters) - Antares Therapeutics said on Wednesday it entered a collaboration with Novartis that could be worth up to ...

Novartis (NVS) stock is in focus as the company collaborates with Antares Therapeutics to develop cancer drugs in a deal ...

Antares Therapeutics on Wednesday entered into a strategic collaboration with Novartis AG NVS aimed at discovering, ...

Antares Therapeutics, a Scorpion spinout with labs in South San Francisco and Boston, has inked a collaboration with Swiss ...

The data showed that del-brax, an “antisense oligonucleotide conjugate” being tested against a muscle-wasting disease, met its primary endpoint in a Phase 1/2 study.

Orionis Biosciences has announced a multi-year collaboration with Novartis to discover and design molecular glue drugs.

Novartis, a Swiss pharmaceutical company, named its Global Head of Drug Development and CMO Vasant Narasimhan, MD, successor to current CEO Joe Jimenez, who will step down Jan. 31. Here are five notes ...